ArticleInternational ophthalmology2025
Survey of eye patients' serum for biomarkers of primary open angle glaucoma in Gwagwalada, Nigeria: serum biomarkers for primary open angle glaucoma.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine and compare serum parameters of primary open angle glaucoma (POAG) patients with that of non-glaucoma eye patients towards discovering biomarkers for POAG.
methodsThe fasting blood of 235 adult eye patients including 96 POAG and 139 non-glaucoma was collected, processed and serum analysed for urea and creatinine, electrolytes, enzymes, protein, bilirubin and lipids.
resultsTwo hundred and thirty-five adult participants of 42 ethnics including 96 with POAG and 139 non-glaucoma were studied. The age range was 19-85 (mean 53.70±13.15 POAG; 46.05±14.00 non-glaucoma) years and (114/235, 48.5%) were males. The mean serum parameters for POAG versus (v) non-glaucoma include Urea 37.04SE2.46 v 27.01SE1.00, P = 0.000; Creatinine 1.08SE0.16 v 1.68SE0.15, P = 0.007; Chloride 86.47SE2.91 v 78.63SE1.43, P = 0.017; Sodium 140.16SE3.82 v 124.83SE3.17, P = 0.953; Potassium 4.70SE0.19 v 4.67SE0.25, P = 0.29; Alkaline Phosphatase (ALP) 17.47SE1.93 v 93.09SE13.87, P = 0.000; Alanine Aminotransferase (ALT) 3.33SE0.61 v 14.95SE1.49, P = 0.000; Aspartate aminotransferase (AST) 16.90SE1.57 v 21.37SE7.85, P = 0.258; Total protein 5.60SE0.15 v 6.03SE0.09, P = 0.015; Albumin 3.26SE0.09 v 3.28SE0.05, P = 0.83; Globulin 2.34SE0.15 v 2.75SE0.09, P = 0.020; Direct bilirubin 0.61SE0.04 v 0.57SE0.04, P = 0.32; Total bilirubin 0.53SE0.06 v 0.90SE0.16, P = 0.14; Cholesterol 169.39SE6.30 v 214.17SE4.60, P = 0.078; High Density Lipoprotein (HDL) 49.53SE2.58 v 45.11SE0.76, P = 0.104, and Triglyceride 80.12SE4.79 v 91.44 SE3.84, P = 0.271.
conclusionThe serum urea, creatinine, chloride, alkaline phosphatase, alanine aminotransferase, total protein, and globulin showed high potential as biomarkers for primary open angle glaucoma. These serum parameters should be further investigated to determine their specificity for primary open angle glaucoma.
Indexed as
Identifiers
40208393What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.